Literature DB >> 11235905

Deregulated expression of cell cycle-associated proteins in solid pseudopapillary tumor of the pancreas.

J Müller-Höcker1, C H Zietz, A Sendelhofert.   

Abstract

Solid pseudopapillary tumor of the pancreas was studied in a 20-year-old woman and a 54-year-old woman. In the younger patient, the tumor had metastasized to the liver 8 years after distal pancreatectomy. In both neoplasms, the distinct histologic pattern of solid, pseudopapillary, and degenerative cystic areas was present. Analysis by means of immunohistochemistry revealed a diffuse expression for vimentin, neuron-specific enolase, and a focal positivity for al-antitrypsin, whereas epithelial markers were negative in the tumor of the older patient and only focally expressed in the tumor of the younger patient. Immunohistochemical analysis of cell cycle-associated proteins provided an overexpression of cyclin D1 and cyclin D3 in both tumors, although to varying degrees. In addition, the cyclin-dependent kinase inhibitors p21, and to a lesser extent p27, were up-regulated just as mdm2. There was no accumulation of p53 protein, and Ki67-positive cells were extremely scarce. Analysis of the liver metastases showed an immunoreactive profile similar to that of the primary tumor. The results show a deregulation of the cell cycle with overexpression of cell cycle-activating proteins D1 and D3 and a probably counterbalancing upregulation of the cyclin-dependent kinase inhibitors p21 and p27. The findings may explain the low pool of Ki67-reactive tumor cells and the generally good clinical outcome of these tumors. Whether a more profound dysbalance of the cell cycle regulation is responsible for the development of metastatic disease remains to be clarified.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11235905     DOI: 10.1038/modpathol.3880255

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  8 in total

1.  Proteomic analysis of solid pseudopapillary tumor of the pancreas reveals dysfunction of the endoplasmic reticulum protein processing pathway.

Authors:  Yi Zhu; Hong Xu; Hao Chen; Junjie Xie; Minmin Shi; Baiyong Shen; Xiaxing Deng; Chao Liu; Xi Zhan; Chenghong Peng
Journal:  Mol Cell Proteomics       Date:  2014-07-05       Impact factor: 5.911

Review 2.  Solid Pseudopapillary Neoplasms of the Pancreas: A Surgical and Genetic Enigma.

Authors:  Leon Naar; Despoina-Amalia Spanomichou; Aikaterini Mastoraki; Vassilios Smyrniotis; Nikolaos Arkadopoulos
Journal:  World J Surg       Date:  2017-07       Impact factor: 3.352

3.  Solid-pseudopapillary tumors of the pancreas are genetically distinct from pancreatic ductal adenocarcinomas and almost always harbor beta-catenin mutations.

Authors:  Susan C Abraham; David S Klimstra; Robb E Wilentz; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; Tsung-Teh Wu; Ralph H Hruban
Journal:  Am J Pathol       Date:  2002-04       Impact factor: 4.307

Review 4.  Solid-pseudopapillary Neoplasms of the Pancreas is still an Enigma: a Clinicopathological Review.

Authors:  Attila Zalatnai; Viktória Kis-Orha
Journal:  Pathol Oncol Res       Date:  2019-06-17       Impact factor: 3.201

Review 5.  Surgical and molecular pathology of pancreatic neoplasms.

Authors:  Wenzel M Hackeng; Ralph H Hruban; G Johan A Offerhaus; Lodewijk A A Brosens
Journal:  Diagn Pathol       Date:  2016-06-07       Impact factor: 2.644

6.  Accuracy of diagnosis of solid pseudopapillary tumor of the pancreas on fine needle aspiration: A multi-institution experience of ten cases.

Authors:  Sidra Jahangir; Asif Loya; Momin T Siddiqui; Noreen Akhter; Muhammed Aasim Yusuf
Journal:  Cytojournal       Date:  2015-12-04       Impact factor: 2.091

Review 7.  Clinical update on the management of pseudopapillary tumor of pancreas.

Authors:  Gandhi Lanke; Faisal S Ali; Jeffrey H Lee
Journal:  World J Gastrointest Endosc       Date:  2018-09-16

8.  The Immunohistochemical Evaluation of Solid Pseudopapillary Tumors of the Pancreas and Pancreatic Neuroendocrine Tumors Reveals ERO1Lβ as a New Biomarker.

Authors:  Junjie Xie; Yi Zhu; Hao Chen; Minmin Shi; Jiangning Gu; Jiaqiang Zhang; Baiyong Shen; Xiaxing Deng; Xi Zhan; Chenghong Peng
Journal:  Medicine (Baltimore)       Date:  2016-01       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.